Trials / Withdrawn
WithdrawnNCT01936961
Study of Immunochemotherapy +/- Hypofractionated Radiation for Complete Response in Solid Tumors
A Pilot Study of Immunochemotherapy +/- Hypofractionated Radiation for Complete Response in Solid Tumors (I-CREST)
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Western Regional Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to use Immunochemotherapy +/- Hypofractionated Radiation for complete response in solid tumors
Conditions
- Metastatic Non-Small Cell Lung Cancer
- Metastatic Colon Cancer
- Metastatic Triple Negative Breast Cancer
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CTLA-4 Antibody | administered intravenously over 90 minutes every 3 weeks for a total of four doses |
| RADIATION | Hypofractionated Radiotherapy |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2014-04-01
- Completion
- 2014-04-01
- First posted
- 2013-09-06
- Last updated
- 2017-06-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01936961. Inclusion in this directory is not an endorsement.